DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort
Authors:
- José Luis Vázquez-HigueraJVJosé Luis Vázquez-Higuera
- Pascual Sánchez-JuanPSPascual Sánchez-Juan
- Eloy Rodríguez-RodríguezEREloy Rodríguez-Rodríguez
- Ignacio MateoIMIgnacio Mateo
- Ana PozuetaAPAna Pozueta
- Ana FrankAFAna Frank
- Isabel SastreISIsabel Sastre
- Fernando ValdiviesoFVFernando Valdivieso
- José BercianoJBJosé Berciano
- María J BullidoMBMaría J Bullido
- Onofre CombarrosOCOnofre Combarros
Open Access
- 8 December 2009
- journal article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10 (1) , 129
Abstract
Background: As dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) has been implicated in the abnormal hyperphosphorylation of tau in Alzheimer's disease (AD) brain, and the development of neurofibrillary tangles, we examined the contribution of this gene to the susceptibility for AD. Methods: We examined genetic variations of DYRK1A by genotyping haplotype tagging SNPs (htSNPs) (rs11701483, rs2835740, rs1137600, rs2835761, rs2835762, rs2154545 and rs8132976) in a group of 634 Spanish AD cases and 733 controls. Results: There were no differences in the genotypic, allelic or haplotypic distributions between cases and controls in the overall analysis or after stratification by APOE ε4 allele. Conclusion: Our negative findings in the Spanish population argue against the hypothesis that DYRK1A genetic variations are causally related to AD risk. Still, additional studies using different sets of patients and control subjects deserve further attention, since supporting evidence for association between DYRK1A gene and AD risk in the Japanese population exists.Keywords
This publication has 14 references indexed in Scilit:
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseNature Genetics, 2009
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Mechanisms of tau-induced neurodegenerationActa Neuropathologica, 2009
- Examination of the current top candidate genes for AD in a genome-wide association studyMolecular Psychiatry, 2009
- Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down SyndromeJournal of Biological Chemistry, 2008
- The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndromeActa Neuropathologica, 2008
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndromeThe FASEB Journal, 2008
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic modelsNeurobiology of Disease, 2005
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984